University Institutional Biosafety Committee
Committee Chair
Mark A. Suckow, D.V.M., Director and Research Associate Professor in the Freimann Life Science Center
Contact Information
(574) 631-5393
Mark.A.Suckow.1@nd.edu
Description of Committee
Responsible for the review and approval of the research conducted at or sponsored by the University that involves the use of recombinant DNA or hazardous materials. These materials include, but are not limited to, infectious agents, oncongenic agents, chemical carcinogens, or other agents that may place research personnel, the general public, or the environment at risk.
Number of Members
6-8
Frequency of Meetings
Once per semester
Reporting Structure
Robert J. Bernhard, Vice President for Research
Committee Members
- Eric Felde, JD, CIP, Director, Research Compliance
- Kelly Jolliff (Local, Non-Affiliated), Infection Prevention Coordinator, Memorial Hospital of South Bend
- Eric Kloss, PhD, Associate Directory, Risk Management & Safety
- Joseph O’Tousa, PhD, Professor, Biological Sciences
- Lisa Phillips, Lab Safety Compliance Program Manager, Risk Management and Safety
Mary Prorok, PhD (Chair), Assistant Chair, Department of Chemistry and Biochemistry - Robin Vida (Local, Non-Affiliated), Director of Health Education, St. Joseph County Health Department
- Ryan Angel, IACUC/IBC Program Coordinator
For more information, click here to visit Notre Dame Research’s page on the IBC Committee.
Information last updated 7/26/2017